Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0486 | 20.1325600663 | 0.2414 | 0.3255 | 0.2022 | 3296011 | 0.27674153 | CS |
| 4 | 0.0156 | 5.68513119534 | 0.2744 | 0.3533 | 0.2022 | 3179046 | 0.28169439 | CS |
| 12 | -0.0616 | -17.5199089875 | 0.3516 | 0.515 | 0.138 | 7174184 | 0.2841753 | CS |
| 26 | -0.474 | -62.0418848168 | 0.764 | 0.89 | 0.138 | 6171618 | 0.41128975 | CS |
| 52 | -8.818 | -96.8159859464 | 9.108 | 10.8 | 0.138 | 3468401 | 0.7171699 | CS |
| 156 | -325.75 | -99.9110538584 | 326.04 | 971.5156 | 0.138 | 1616108 | 134.64061609 | CS |
| 260 | -27.7908 | -98.9672658899 | 28.0808 | 2640 | 0.138 | 1153153 | 205.39417295 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
